BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
34 hedge funds and large institutions have $266K invested in BRAINSTORM CELL THERAPUTC in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
76% less capital invested
Capital invested by funds: $1.09M → $266K (-$825K)
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$29.1K | |
| 2 | +$13.6K | |
| 3 | +$12.2K | |
| 4 |
LPL Financial
San Diego,
California
|
+$12K |
| 5 |
AIP
Almanack Investment Partners
Wayne,
Pennsylvania
|
+$11.2K |
Top Sellers
| 1 | -$870K | |
| 2 | -$20.4K | |
| 3 | -$4.01K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$265 |
| 5 |
JPMorgan Chase & Co
New York
|
-$215 |
